Sign in to continue:

Sunday, April 12th, 2026

Author: Minichart

us corporate news

Surgery Partners, Inc. Reports Q4 and Full Year 2025 Results, Announces $20 Million Share Repurchase Program and Provides 2026 Guidance 1

Minichart
March 3, 2026

Surgery Partners, Inc. Q4 & Full Year 2025 Earnings Report –...

Continue Reading 0
SGX corporate News

State Street SPDR Straits Times Index ETF (ES3): 2026 Prospectus, Key Information, Risks, and Top Holdings

Minichart
March 3, 2026

State Street SPDR Straits Times Index ETF: Key Investor Info...

Continue Reading 0
us corporate news

CarMax, Inc. Amended and Restated Severance Agreement Filing – Key Terms, Competitors List, and SEC XBRL Data (March 2026)

Minichart
March 3, 2026

CarMax, Inc. Files Amended and Restated Severance Agreements...

Continue Reading 0
SGX corporate News

State Street SPDR Straits Times Index ETF (ES3) – Key Features, Risks, Fees & Investment Guide

Minichart
March 3, 2026

State Street SPDR Straits Times Index ETF: Key Investor High...

Continue Reading 0
us corporate news

Asana Appoints Aziz Megji as Chief Financial Officer, Succeeding Sonalee Parekh in March 2026 1

Minichart
March 3, 2026

Asana Announces CFO Transition: Aziz Megji to Succeed Sonale...

Continue Reading 0
us corporate news

FB Bancorp, Inc. (FBLA) Files Form 8-K Detailing Acquisition, Company Information, and Nasdaq Listing

Minichart
March 3, 2026

FB Bancorp, Inc. (NASDAQ: FBLA) 8-K Filing: Asset Sale Compl...

Continue Reading 0
us corporate news

Akari Therapeutics, Plc Form 8-K SEC Filing Summary – Company Information, Address, and Registered Securities (March 2, 2026)

Minichart
March 3, 2026

Akari Therapeutics, Plc – Shareholder Meeting Results and Wa...

Continue Reading 0
us corporate news

Iterum Therapeutics plc Form 8-K Filing: Company Details, Delisting Notice, and NASDAQ Information (Feb 24, 2026)

Minichart
March 3, 2026

Iterum Therapeutics Faces Nasdaq Delisting: Key Details for ...

Continue Reading 0
us corporate news

CNS Pharmaceuticals Appoints New Chief Medical Officer and Announces Executive Transitions in 2026

Minichart
March 3, 2026

CNS Pharmaceuticals, Inc. - Form 8-K Summary and Key Shareho...

Continue Reading 0
us corporate news

Broadcom Inc. 8-K SEC Filing Summary – Company Details, Stock Information, and Entity Data (Feb 2026)

Minichart
March 3, 2026

Broadcom Inc. Announces Retirement of Director Eddy W. Harte...

Continue Reading 0